IRulya Therapeutics Inc.

IRLA·NasdaqCM·Healthcare
Compare
31.67−1.49 (−4.49%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close33.16
Open33.80
Day range31.4534.15
52-week range15.10910.00
Off day high−7.25%
Off 52-week high−96.52%
Volume57.90K
Avg. volume (3M)44.59K
Market cap32.21M
EPS (TTM)-214.01
Forward P/E-6.76
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.79
Shares outstanding1.02M
Short interest15.26% of float
Earnings dateNov 12, 2026 (est.)
Analyst target75.00
Profit margin0.00%

Against its peers

Compare in full ›
IRLA ALGS INMB INDP TOVX AIM
Market cap 32.21M 31.35M 41.18M 439.70M 8.72M 6.42M
P/E (TTM) — — — — 0.3 —
Forward P/E -6.8 -1.0 -3.1 -2.4 -1.0 -0.4
Price/book -0.9 1.0 1.8 38.8 0.7 0.6
Dividend yield — — — — — —
1-year change −89.51% −29.30% −18.40% +25.10% −29.63% −90.12%
Today −4.49% +5.68% +0.76% +1.85% +4.40% +0.19%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All IRLA news ›
TradingView·Positive

Asset turnover of Quince Therapeutics, Inc. – NASDAQ:IRLA

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular…

TradingView·Positive

Enterprise value of Quince Therapeutics, Inc. – NASDAQ:IRLA

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular…

MarketScreener·

IRulya Therapeutics Inc. : Insider Transactions

Follow insider transactions on IRulya Therapeutics Inc. in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions IRulya Therapeutics Inc. Biotechnology & Medical Research Latest…

From the 4Search news index, newest first.

In the news

20mentions in 30 days
14with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 20 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance